Koers Shilpa Medicare Ltd NSE India S.E.
Aandelen
INE790G01023
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
09/04 | Shilpa Medicare krijgt goedkeuring van bestuur voor lancering QIP | MT |
28/03 | Shilpa Medicare's Life Science Arm benoemt CEO | MT |
Omzet 2022 | 11,47 mld. 138 mln. 128 mln. | Omzet 2023 | 10,52 mld. 126 mln. 117 mln. | Marktkapitalisatie | 19,91 mld. 239 mln. 222 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 607 mln. 7,28 mln. 6,76 mln. | Nettowinst (verlies) 2023 | -325 mln. -3,9 mln. -3,62 mln. | EV/omzet 2022 | 3,58 x |
Nettoschuld 2022 | 6,58 mld. 78,93 mln. 73,28 mln. | Nettoschuld 2023 | 7,79 mld. 93,46 mln. 86,76 mln. | EV/omzet 2023 | 2,63 x |
K/w-verhouding 2022 |
54,7
x | K/w-verhouding 2023 |
-61,3
x | Werknemers | - |
Dividendrendement 2022 |
0,28% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 39,28% |
Recentste transcriptie over Shilpa Medicare Ltd
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 63 | 20-11-87 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 31-05-21 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 63 | 20-11-87 | |
Director/Board Member | 58 | 02-09-21 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 02-09-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. |